This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.

Keyword Search

Keyword Search Criteria: futility returned 8 record(s)
Monday, 08/02/2010
Futility Assessment Utilizing Conditional Power in a Phase III Clinical Trial
Yan Sun, Amgen Inc.
8:35 AM

Sample Size and Power Considerations for Futility Trial Design: Buying Power vs. Spending Beta
Thomas Dobbins, Merck & Co., Inc.
8:50 AM

Should the Conditional Type I Error Be Controlled?
Tie-Hua Ng, FDA
9:50 AM

Two-Stage Designs with Additional Futility Tests for Phase II Clinical Trials with Heterogeneous Patient Populations
Myron N. Chang, University of Florida; Sin-Ho Jung, Duke University
10:05 AM

Wednesday, 08/04/2010
An Adaptive Futility Monitoring Method with Time-Varying Conditional Power Boundary
Ying Zhang, The University of Iowa; William Clarke, The University of Iowa
10:55 AM

The Role of Bayesian Statistics in Confirmatory Drug Development Trials
David Ohlssen, Novartis Pharmaceuticals Corporation
2:30 PM

Adding a Prediction Interval Futility Analysis to a Group Sequential Trial
John Loewy, ARIAD Pharmaceuticals; David Dorer, ARIAD Pharmaceuticals
3:25 PM

Thursday, 08/05/2010
Design and Trial Operational Considerations for a Phase II Two-Stage Adaptive Trial
Weili He, Merck & Co., Inc.; Madhuja Mallick, Merck & Co., Inc.; Yevgen Tymofyeyev, Merck & Co., Inc.; James A. Bolognese, Cytel Inc.
10:55 AM




2010 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.